Literature DB >> 21920614

The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: a summary of three years report.

Wan Azman Wan Ahmad1, Rosli Mohd Ali, Mehrunnissa Khanom, Chee Kok Han, Liew Houng Bang, Alan Fong Yean Yip, Azmee Mohd Ghazi, Omar Ismail, Robaayah Zambahari, Sim Kui Hian.   

Abstract

INTRODUCTION: The Malaysian National Cardiovascular Disease Database (NCVD) team presents Percutaneous Coronary Intervention (PCI) Registry report for the year 2007 to 2009. It provides comprehensive information regarding practice and outcome of PCI in Malaysia.
METHODOLOGY: It was a voluntary, multi-centered, observational, cohort study and included patients of 18 years or above who underwent PCI at eleven participating centers in Malaysia from the year 2007 to 2009. RESULT: Ten thousand six hundred and two patients underwent 11,498 PCI procedures with 18,116 stents for 15,538 lesions. Mean age of the patients was 57 years and more than 98% of patients had at least one cardiovascular risk factor. A significant number of our patients were diabetic (50%) and had renal impairment (44.7% had ≤ stage 3 chronic kidney disease) at the time of procedure. Fifty eight percent of the lesions were type B2 or type C lesion. Twenty eight percent of the lesions had high risk characteristics. Procedural success rate was about 97% and post-procedural complications were low. Overall in-hospital, all cause mortality was 1%, of which 85% were cardiac related deaths. The poor prognostic factors for in-hospital mortality were acute coronary syndrome cases, higher Killip class and increasing age.
CONCLUSION: Compared to other registries, Malaysian patients undergoing PCI were much younger with high prevalence of risk factors. In spite of complex and high risk lesions, procedural success was high, with overall low mortality rate. NCVD-PCI Registry aims to improve over-all cardiac services in Malaysia through its ongoing journey.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21920614     DOI: 10.1016/j.ijcard.2011.08.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  In-hospital risk stratification algorithm of Asian elderly patients.

Authors:  Sazzli Kasim; Sorayya Malek; Song Cheen; Muhammad Shahreeza Safiruz; Wan Azman Wan Ahmad; Khairul Shafiq Ibrahim; Firdaus Aziz; Kazuaki Negishi; Nurulain Ibrahim
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

2.  The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study.

Authors:  Muhammad Dzafir Ismail; Wan Azman Wan Ahmad; Matthias Leschke; Matthias Waliszewski; Michael Boxberger; Imran Zainal Abidin; Ahmad Syadi Mahmood Zuhdi
Journal:  Springerplus       Date:  2016-09-27

3.  Comparison of the treatment practice and hospitalization cost of percutaneous coronary intervention between a teaching hospital and a general hospital in Malaysia: A cross sectional study.

Authors:  Kun Yun Lee; Wan Azman Wan Ahmad; Ee Vien Low; Siow Yen Liau; Lawrence Anchah; Syuhada Hamzah; Houng-Bang Liew; Rosli B Mohd Ali; Omar Ismail; Tiong Kiam Ong; Mas Ayu Said; Maznah Dahlui
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

4.  Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam.

Authors:  Hoa T T Vu; Hung M Pham; Hoai T T Nguyen; Quang N Nguyen; Loi D Do; Ngoc M Pham; Richard Norman; Rachel R Huxley; Crystal M Y Lee; Christopher M Reid
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-04

5.  Intervention and in-hospital pharmacoterapies in octogenarian with acute coronary syndrome: a 10-year retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.

Authors:  Siti Z Suki; Ahmad S M Zuhdi; ' Abqariyah A Yahya; Nur L Zaharan
Journal:  BMC Geriatr       Date:  2022-01-04       Impact factor: 3.921

Review 6.  From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research".

Authors:  Hector A Cabrera-Fuentes; Julian Aragones; Jürgen Bernhagen; Andreas Boening; William A Boisvert; Hans E Bøtker; Heerajnarain Bulluck; Stuart Cook; Fabio Di Lisa; Felix B Engel; Bernd Engelmann; Fulvia Ferrazzi; Péter Ferdinandy; Alan Fong; Ingrid Fleming; Erich Gnaiger; Sauri Hernández-Reséndiz; Siavash Beikoghli Kalkhoran; Moo Hyun Kim; Sandrine Lecour; Elisa A Liehn; Michael S Marber; Manuel Mayr; Tetsuji Miura; Sang-Bing Ong; Karlheinz Peter; Daniel Sedding; Manvendra K Singh; M Saadeh Suleiman; Hans J Schnittler; Rainer Schulz; Winston Shim; Daniel Tello; Carl-Wilhelm Vogel; Malcolm Walker; Qilong Oscar Yang Li; Derek M Yellon; Derek J Hausenloy; Klaus T Preissner
Journal:  Basic Res Cardiol       Date:  2016-10-14       Impact factor: 17.165

7.  Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.

Authors:  Padmaa Venkatason; Nur Lisa Zaharan; Muhammad Dzafir Ismail; Wan Azman Wan Ahmad; Ahmad Syadi Mahmood Zuhdi
Journal:  Eur J Clin Pharmacol       Date:  2018-03-26       Impact factor: 2.953

8.  Establishment of a Percutaneous Coronary Intervention Registry in Vietnam: Rationale and Methodology.

Authors:  Hoa T T Vu; Hoai T T Nguyen; Hung M Pham; Loi D Do; Quang N Nguyen; Richard Norman; Rachel R Huxley; Ngoc M Pham; Crystal M Y Lee; Christopher M Reid
Journal:  Glob Heart       Date:  2020-04-08

9.  Short- and long-term mortality prediction after an acute ST-elevation myocardial infarction (STEMI) in Asians: A machine learning approach.

Authors:  Firdaus Aziz; Sorayya Malek; Khairul Shafiq Ibrahim; Raja Ezman Raja Shariff; Wan Azman Wan Ahmad; Rosli Mohd Ali; Kien Ting Liu; Gunavathy Selvaraj; Sazzli Kasim
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.